NCT05044624

Brief Summary

: Soft Tissue Sarcomas are rare mesenchymal tumors with many subtypes. Clean margin-wide resection is recommended for treatment. The guidelines recommend that sarcoma treatments be carried out in sarcoma centers. In this study, the location, histopathological features, clinical and demographic features, recurrence, and prognosis of retroperitoneal sarcomas were investigated.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2016

Longer than P75 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2016

Completed
5.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2021

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

September 2, 2021

Completed
14 days until next milestone

First Posted

Study publicly available on registry

September 16, 2021

Completed
Last Updated

September 16, 2021

Status Verified

September 1, 2021

Enrollment Period

5.3 years

First QC Date

September 2, 2021

Last Update Submit

September 9, 2021

Conditions

Retroperitoneal SarcomaMargin, Tumor-Free

Keywords

Soft tissue sarcomaSurgeryMultidisciplinary Sarcoma Team

Outcome Measures

Primary Outcomes (1)

  • Clean margin wide resection

    effect of clean surgical margin on recurrence

    63 month

Study Arms (1)

Margin, Tumor-Free

OTHER
Procedure: retroperitoneal mass excision

Interventions

retroperitoneal mass excisionPROCEDURE

retroperitoneal mass excision

Margin, Tumor-Free

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients operated with the diagnosis of intra-abdominal mass
  • patients diagnosed with pathological sarcoma subclasses

You may not qualify if:

  • Patients younger than 18 years
  • Visceral organ-origin sarcomas
  • extremity sarcomas
  • GIST

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Margins of ExcisionSarcoma

Condition Hierarchy (Ancestors)

Morphological and Microscopic FindingsPathological Conditions, Signs and SymptomsNeoplasms, Connective and Soft TissueNeoplasms by Histologic TypeNeoplasms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Investigator

Study Record Dates

First Submitted

September 2, 2021

First Posted

September 16, 2021

Study Start

March 1, 2016

Primary Completion

June 1, 2021

Study Completion

June 1, 2021

Last Updated

September 16, 2021

Record last verified: 2021-09

Data Sharing

IPD Sharing
Will share